Jing Luo

EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells

Shuo Huang, Zhongyu Wang, Jie Zhou et al. · Cancer Research · 2019 · 184 citations · Full text

Medicine, Immunology, Oncology +17

PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway

Jing Luo, Yu Yao, Saiguang Ji et al. · Cancer Cell International · 2019 · 82 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK

Chenxu Ge, Jun Tan, Xianling Dai et al. · Nature Communications · 2022 · 60 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer

Lilong Xia, Xinhai Zhu, Lei Zhang et al. · Biotechnology and Applied Biochemistry · 2019 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17

DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell

Jing Luo, Kaichao Liu, Yu Yao et al. · Cancer Letters · 2019 · 35 citations

Life Sciences, Molecular Biology, Oncology +14